Author Response: Unveiling Statins and Genetics in Age-Related Macular Degeneration Progression: What Is the Appropriate Modeling Strategy?
作者信息
Barreto Patricia, Farinha Claudia, Coimbra Rita, Silva Rufino
机构信息
AIBILI-Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal.
Coimbra Institute for Clinical and Biomedical Research, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
出版信息
Invest Ophthalmol Vis Sci. 2025 Mar 3;66(3):3. doi: 10.1167/iovs.66.3.3.
Abstract
摘要
相似文献
1
Author Response: Unveiling Statins and Genetics in Age-Related Macular Degeneration Progression: What Is the Appropriate Modeling Strategy?作者回应：揭示他汀类药物与遗传学在年龄相关性黄斑变性进展中的作用：何种合适的建模策略？
Invest Ophthalmol Vis Sci. 2025 Mar 3;66(3):3. doi: 10.1167/iovs.66.3.3.
2
Unveiling Statins and Genetics in Age-Related Macular Degeneration Progression: What Is the Appropriate Modeling Strategy?揭示他汀类药物与遗传学在年龄相关性黄斑变性进展中的作用：何种合适的建模策略？
Invest Ophthalmol Vis Sci. 2025 Jan 2;66(1):25. doi: 10.1167/iovs.66.1.25.
3
Unveiling Statins and Genetics in Age-Related Macular Degeneration: The Coimbra Eye Study-Report 9.揭开他汀类药物与年龄相关性黄斑变性的遗传学关联：科英布拉眼科研究-报告 9.
Invest Ophthalmol Vis Sci. 2024 Jun 3;65(6):38. doi: 10.1167/iovs.65.6.38.
4
Statins for age-related macular degeneration.用于年龄相关性黄斑变性的他汀类药物。
Cochrane Database Syst Rev. 2009 Jul 8(3):CD006927. doi: 10.1002/14651858.CD006927.pub2.
5
The Question of a Role for Statins in Age-Related Macular Degeneration.他汀类药物在年龄相关性黄斑变性中的作用问题。
Int J Mol Sci. 2018 Nov 21;19(11):3688. doi: 10.3390/ijms19113688.
6
Statins for age-related macular degeneration.用于年龄相关性黄斑变性的他汀类药物。
Cochrane Database Syst Rev. 2012 Mar 14;3(3):CD006927. doi: 10.1002/14651858.CD006927.pub3.
7
Statins and the progression of age-related macular degeneration in the United States.他汀类药物与美国年龄相关性黄斑变性的进展。
PLoS One. 2021 Aug 4;16(8):e0252878. doi: 10.1371/journal.pone.0252878. eCollection 2021.
8
Can HMG Co-A reductase inhibitors ("statins") slow the progression of age-related macular degeneration? The age-related maculopathy statin study (ARMSS).羟甲基戊二酸单酰辅酶A还原酶抑制剂（“他汀类药物”）能否减缓年龄相关性黄斑变性的进展？年龄相关性黄斑病变他汀类药物研究（ARMSS）。
Clin Interv Aging. 2008;3(3):581-93. doi: 10.2147/cia.s2748.
9
HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration?HMG辅酶A还原酶抑制剂（他汀类药物）：它们在年龄相关性黄斑变性中起作用吗？
Surv Ophthalmol. 2005 Mar-Apr;50(2):194-206. doi: 10.1016/j.survophthal.2004.12.002.
10
Statins for age-related macular degeneration.用于年龄相关性黄斑变性的他汀类药物。
Cochrane Database Syst Rev. 2015 Feb 11;2(2):CD006927. doi: 10.1002/14651858.CD006927.pub4.
本文引用的文献
1
Unveiling Statins and Genetics in Age-Related Macular Degeneration Progression: What Is the Appropriate Modeling Strategy?揭示他汀类药物与遗传学在年龄相关性黄斑变性进展中的作用：何种合适的建模策略？
Invest Ophthalmol Vis Sci. 2025 Jan 2;66(1):25. doi: 10.1167/iovs.66.1.25.
2
Unveiling Statins and Genetics in Age-Related Macular Degeneration: The Coimbra Eye Study-Report 9.揭开他汀类药物与年龄相关性黄斑变性的遗传学关联：科英布拉眼科研究-报告 9.
Invest Ophthalmol Vis Sci. 2024 Jun 3;65(6):38. doi: 10.1167/iovs.65.6.38.
Zotero 插件